Researchers Shocked by Mushroom Study Results

By Dr. Becker

In a study conducted at the University of Pennsylvania’s School of Veterinary Medicine and published recently in an open-access article in the journal Evidence-Based Complementary and Alternative Medicine1, dogs with hemangiosarcoma -- an aggressive, malignant cancer that develops in the cells of blood vessels – were given a compound derived from a type of mushroom, Coriolus versicolor.

According to researchers, the patients given this compound had the longest survival times ever reported for dogs with this form of cancer. This is certainly promising news, as this mushroom compound could offer an alternative to chemotherapy or a complementary treatment to traditional cancer therapies for dogs and people. >